Biogen Inc

Biogen Inc (NASDAQ:BIIB) (fair value) by 6% Website https://www.biogen.com/ Sector Healthcare Industry Drug Manufacturers General Fiscal Year End…

Biogen Inc (NASDAQ:BIIB) over-valued by 21% Website https://www.biogen.com/ Sector Healthcare Industry Drug Manufacturers General Fiscal Year End Dec…

Biogen Inc (NASDAQ:BIIB) under-valued by 10% Website https://www.biogen.com/ Sector Healthcare Industry Drug Manufacturers General Fiscal Year End Dec…

Biogen Inc (NASDAQ:BIIB) (fair value) by 0% Website https://www.biogen.com/ Sector Healthcare Industry Drug Manufacturers General Fiscal Year End…

Biogen Inc (NASDAQ:BIIB) under-valued by 10% Website https://www.biogen.com/ Sector Healthcare Industry Drug Manufacturers General Fiscal Year End Dec…

Biogen Inc (NASDAQ:BIIB) over-valued by 10% Website https://www.biogen.com/ Sector Healthcare Industry Drug Manufacturers General Fiscal Year End Dec…

Biogen Inc (NASDAQ:BIIB) over-valued by 8% Website https://www.biogen.com/ Sector Healthcare Industry Drug Manufacturers General Fiscal Year End Dec…

Biogen Inc (NASDAQ:BIIB) over-valued by 11% Website https://www.biogen.com/ Sector Healthcare Industry Drug Manufacturers General Fiscal Year End Dec…

Biogen Inc (NASDAQ:BIIB) (fair value) by 5% Website https://www.biogen.com/ Sector Healthcare Industry Drug Manufacturers General Fiscal Year End…

Biogen Inc (NASDAQ:BIIB) over-valued by 14% Website https://www.biogen.com/ Sector Healthcare Industry Drug Manufacturers General Fiscal Year End Dec…